← Leaderboards
Janak K Padia
Primetime Life Sciences, Llc
$5,783,007
Attributed
$5,783,007
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,783,007 · 2
By mechanism
R44$5,783,007 · 2
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Rodent”
- Xinhua Li · Nano Terra, Inc.$23,903,965
- Rui M. Costa · Columbia University Health Sciences$13,762,381
- Nanthia A Suthana · University Of California Los Angeles$12,058,212
- Karen Marie Dobos · Colorado State University$11,585,271
- Anna Upton · Global Alliance For Tb Drug Development$10,496,979
- Jay Evans · University Of Montana$9,566,206
Research focus
RodentProductionResistanceOralPlasmaPrevalenceOral AdministrationDrug KineticsGenotoxicityMouse ModelPharmaceutical PreparationsPharmacologyPreclinical DevelopmentPreclinical StudyClinical TrialsClinical ResearchDoseDrug ExposureAdverse EffectsFormulationAnimalsMetabolismPersonsSafety
Grant awards (8)
Development of PTLS-209 for treatment for giardiasis$1,000,000
R44 · FY2025 · AI · contact PI
Development of PTLS-209 for treatment for giardiasis$915,901
R44 · FY2024 · AI · contact PI
Development of PTLS-209 for treatment for giardiasis$633,977
R44 · FY2023 · AI · contact PI
Development of PTLS-209 for treatment for giardiasis$300,000
R44 · FY2022 · AI · contact PI
Development of an adenosine A1 receptors agonist, MRS5474 for the treatment of chronic depression$935,028
R44 · FY2021 · MH · contact PI
Development of an adenosine A1 receptors agonist, MRS5474 for the treatment of chronic depression$840,580
R44 · FY2020 · MH · contact PI
Development of an adenosine A1 receptors agonist, MRS5474 for the treatment of chronic depression$807,479
R44 · FY2019 · MH · contact PI
Development of an adenosine A1 receptors agonist, MRS5474 for the treatment of chronic depression$350,042
R44 · FY2018 · MH · contact PI